Ethyl 2-{[2-(4-chlorophenyl)-6-nitro-1H-1,3-benzodiazol-1-yl]oxy}propanoate

Catalog No. :
ACOUXK122
CAS No. :
282523-41-5
Molecular Formula :
C18H16ClN3O5
Molecular Weight :
389.80

IUPAC Name:ethyl 2-((2-(4-chlorophenyl)-6-nitro-1H-benzo[d]imidazol-1-yl)oxy)propanoate

Ethyl 2-{[2-(4-chlorophenyl)-6-nitro-1H-1,3-benzodiazol-1-yl]oxy}propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-{[2-(4-chlorophenyl)-6-nitro-1H-1,3-benzodiazol-1-yl]oxy}propanoate
IUPAC Nameethyl 2-((2-(4-chlorophenyl)-6-nitro-1H-benzo[d]imidazol-1-yl)oxy)propanoate
MDL No.MFCD00141410
Molecular FormulaC18H16ClN3O5
Molecular Weight389.80
SMILESCC(ON1C(C2=CC=C(Cl)C=C2)=NC3=CC=C([N+]([O-])=O)C=C31)C(OCC)=O
InChI KeyXXZFOYHDEVYSHL-UHFFFAOYSA-N
SynonymETHYL 2-([2-(4-CHLOROPHENYL)-6-NITRO-1H-1,3-BENZIMIDAZOL-1-YL]OXY)PROPANOATE;Propanoic acid, 2-[[2-(4-chlorophenyl)-6-nitro-1H-benzimidazol-1-yl]oxy]-, ethyl ester
CAS No.282523-41-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOUXK122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOUXK122 route product structure diagram
    ACOUXK122282523-41-5
Inquiry

2. ACOUXK122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOUXK122 route product structure diagram
    ACOUXK122282523-41-5
Inquiry

Comments (0)